Everyone Healthy Library
Choledocholithiasis
Condition / disease reference page from the Everyone Healthy database.
Connected health information
Explore this condition in a clear order
Linked signs and symptoms
11Each sign/symptom opens its own page and links back to related conditions.
Linked drugs / medications
0No linked drugs are listed yet.
Treatments, therapies and supportive options
12Grouped by treatment type. These are educational database links, not personal treatment recommendations. Evidence labels are shown only where stored in the EH database.
Endoscopic procedures
1Medical therapy
6- CholecystectomyWeakly in Favour(Low Evidence)
- CholedochoduodenostomyWeakly in Favour(Low Evidence)
- CholedochotomyWeakly in Favour(Low Evidence)
- Endoscopic Retrograde Cholangiopancreatography (ERCP)Weakly in Favour(Low Evidence)
- Percutaneous ExtractionWeakly in Favour(Low Evidence)
- SphincterotomyWeakly in Favour(Low Evidence)
Linked diagnostic tests and investigations
9These are pulled from both EH diagnostic-test link tables, including the older large test-link table.
- Blood Tests
- Endoscopic Retrograde Cholangiopancreatography (ERCP)
- Fecal Fat Determination (Fat Absorption Test, Fecal Fat Stain)
- Gamma-Glutamyltransferase (GGT) Concentration
- haptoglobin (Hp) concentration
- Lactate Dehydrogenase Concentration
- Prothrombin Time (PT)
- Urine bilirubin Concentration
- Urine Urobilinogen Concentration
Biological and test markers
7This visual map uses existing EH database links to show biological agents and lab markers reported as increased, decreased, or associated with this condition. These are educational relationships only; test results must be interpreted by a qualified clinician because ranges vary by lab, method, age, sex and clinical context.
Often increased
7- Fecal FatReference range exampleAll: 1,000–7,000 mg/24hrsLinked diagnostic tests1Fecal Fat Determination (Fat Absorption Test, Fecal Fat Stain)
- Gamma-Glutamyltransferase (GGT)Reference range exampleAdult ( > 16y), Female: 6–30 units/L; Adult ( > 16y), Male: 6–38 units/LLinked diagnostic tests1Gamma-Glutamyltransferase (GGT) Concentration
- haptoglobin (Hp)Reference range example45–200 mg/dLLinked diagnostic tests1haptoglobin (Hp) concentration
- Lactate Dehydrogenase (LDH)Reference range exampleInfant (0 - 1y): 120–250 units/L; Adult ( > 16y): 100–200 units/LLinked diagnostic tests1Lactate Dehydrogenase Concentration
- Prothrombin TimeReference range exampleAdult ( > 16y): 10–13 secondsLinked diagnostic tests1Prothrombin Time (PT)
- Urine bilirubinReference range exampleAll: 0–0.02 mg/dLLinked diagnostic tests1Urine bilirubin Concentration
- Urobilinogen (Urine)Reference range exampleAll: 0.1–1 mg/dLLinked diagnostic tests1Urine Urobilinogen Concentration
Often decreased
0No markers in this group.
Other associated markers
0No markers in this group.
Introduction / full article
Choledocholithiasis
Choledocholithiasis
Choledocholithiasis is a medical term used when an individual has a gallstone in a structure called common bile duct where bile passes from gallbladder to the intestine. [1] Gallstones can be primary, secondary, residual or recurrent. A primary stone is one which originates in the bile duct. Secondary stone comes from gallbladder but travels to the bile duct. Residual stone refers to a stone that was left out at the time of surgical operation called cholecystectomy which usually manifests in less than 3 years after the surgery. Lastly, recurrent stones are those that develop in ducts more than 3 years after an individual undergoes surgery. [2]
Epidemiology
Majority of cases in developed countries involve secondary stones. [2] Some ethnic groups like American Indians and Mexican-Americans are said to be more prone to develop gallstones while those from Asian descent are more likely to have stones located in the bile duct in particular. The chance to have the condition increases with age. Female predilection has been reported as well. [3]
Causes
Individuals who had history of gallstones or disease of the gallbladder have increased chances of having the condition. Even those patients who already have their gallbladder taken away via surgery may still develop choledocholithiasis. Some of the identified risk factors include being obese, pregnant, having sedentary lifestyle and people who are undergoing prolonged fasting. A diet which is high in fat and calories but low in fiber has been implicated to the development of choledocholithiasis. Genetics also is another essential factor. [3]
Signs and Symptoms
If there is an obstruction, the individual may experience symptoms including an abdominal pain positioned at the right or middle upper area which can radiate to the back or to the shoulder. There can also be yellowing of the skin and sclera of the eyes referred to as jaundice. Fever, nausea and vomiting are also common. [4]
Diagnosis
To identify the location of the stones, laboratory exams like abdominal ultrasound Endoscopic Retrograde Cholangiography (ERCP), Magnetic Resonance Cholangiopancreatography (MRCP) and CT scan can be performed. Blood tests can also be requested. [5]
Treatment
Stones may be taken out or be allowed to pass through the duct in procedures like ERCP or sphincterotomy. Depending on the case, other surgical processes may be needed. [5]
References:
1. http://health.nytimes.com/health/guides/disease/choledocholithiasis/overview.html
3. http://www.healthline.com/health/choledocholithiasis
4. http://www.pennmedicine.org/encyclopedia/em_PrintArticle.aspx?gcid=000274
5. http://www.nlm.nih.gov/medlineplus/ency/article/000274.htm